Cancer can change in response to its surroundings and to treatment, making resistance a moving target. Hillman Cancer Center researchers are studying these changes from multiple angles to develop more precise, durable, and adaptable approaches to cancer immunotherapy.
A Moving Target: Advancing Cancer Immunotherapy
